A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior
Launched by AUBURN UNIVERSITY · Dec 9, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new ways to help children and teenagers with challenging behaviors, such as tantrums or crying, learn better self-control and communication skills. The researchers want to understand if innovative teaching methods can help these young people keep using their new skills, even when they encounter different situations or people. They will also look at how factors like memory and decision-making play a role in the effectiveness of these treatments.
To participate, children aged 6 to 17 with intellectual and developmental disabilities (IDD) who display challenging behaviors that usually get them attention or access to things they want might be eligible. During the study, participants will complete assessments to identify what activities they enjoy and what triggers their challenging behaviors. They will also learn new ways to communicate their needs and take part in activities that help researchers understand how they respond to different rewards. This trial is currently looking for participants, and it's a great opportunity for families seeking support for their children's behavior challenges.
Gender
ALL
Eligibility criteria
- • We will include individuals between the ages of 6 to 17 with IDD who have at least one topography of SPB that is maintained by social positive (e.g., attention, access to preferred items) reinforcement. The age range is driven by the need to maximize the number of participants; there is no evidence to suggest that age is a relevant variable regarding relapse of SPB.
About Auburn University
Auburn University is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to interdisciplinary collaboration, the university leverages its diverse expertise in health sciences, engineering, and social sciences to conduct rigorous research that addresses pressing healthcare challenges. Auburn University’s Clinical Trials Office ensures adherence to ethical standards and regulatory compliance, facilitating high-quality research that contributes to the scientific community and enhances patient care. Through its robust infrastructure and support services, Auburn University is poised to make significant contributions to clinical research and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Auburn, Alabama, United States
Patients applied
Trial Officials
John Falligant, PhD
Principal Investigator
Auburn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported